Management of Severe Hyperglycemia in Elderly Patients

Introduction to Appropriate Therapy

• The American Diabetes Association recommends basal-bolus insulin regimens as the standard of care for elderly hospitalized or acutely ill patients with poor glycemic control, not oral agents 1
• Non-insulin antihyperglycemic agents are not recommended for management of hyperglycemia in hospitalized or acutely ill patients due to slow onset of action and inability to rapidly adjust to changing metabolic needs 1

Optimizing Insulin Therapy

• For an elderly patient with glucose of 355 mg/dL, the basal insulin should be titrated upward to achieve fasting glucose targets of 100-140 mg/dL 1
• Consider increasing basal insulin by 10-20% and reassess in 2-3 days 1
• Basal-bolus regimens with insulin analogs result in better glycemic control and lower rates of complications compared with sliding-scale insulin alone in elderly patients 1

Prandial Insulin Coverage

• This patient needs prandial insulin before meals, not sitagliptin, with a suggested initiation or adjustment of rapid-acting insulin at 4 units or 10% of basal dose before the largest meal 1, 4
• Initiate or adjust rapid-acting insulin (lispro, aspart, or glulisine) and titrate based on postprandial glucose monitoring 4

Age-Appropriate Glycemic Targets

• For an elderly patient, an HbA1c target of 7.5-8.0% is appropriate, balancing glycemic control against hypoglycemia risk 5, 6

Considerations for Sitagliptin

• Sitagliptin is ineffective when baseline blood glucose exceeds 180 mg/dL, and typically reduces HbA1c by only 0.5-0.8% 2, 3
• Sitagliptin could potentially be added later once glucose is controlled to reduce total insulin requirements and simplify the regimen 2, 3

Safety and Efficacy

• Sitagliptin has a low hypoglycemia risk and is weight-neutral, which are advantages in elderly patients 5
• When combined with basal insulin in controlled patients, sitagliptin showed no significant differences in hypoglycemia frequency compared to basal-bolus insulin 5

Critical Pitfalls to Avoid

• Do not delay insulin intensification by adding oral agents when severe hyperglycemia is present, as this patient needs immediate insulin optimization 1, 2
• Avoid overbasalization, as the problem is likely inadequate prandial coverage, not insufficient basal insulin 4
• Monitor for hypoglycemia closely when adjusting insulin in elderly patients, as they have reduced hypoglycemia awareness and higher risk of falls 5, 6